Asia University has partnered with NucleicAI LLC, a forward-thinking company that specializes in AI-driven genomics, precision medicine, and health intelligence, to create a Sovereign AI Life Science Data Platform located in Taiwan. This platform will operate within the country to ensure secure data sharing, advanced analytical capabilities, and research collaboration, while keeping strict control over data sovereignty. The partnership was officially announced at the IEEE International Conference on AI × Medicine, Health, and Care in Taichung, which featured a keynote speech by Professor Alireza Haghighi and remarks from Asia University President Jeffrey J.P. Tsai.
Health Technology Insights: Microsoft Healthcare Executive Kim Swafford Joins RAAPID Advisory Board
President Jeffrey J.P. Tsai shared his excitement about the collaboration, noting that this partnership represents a major step in building a modern health data ecosystem. He mentioned that combining global technological progress with local knowledge supports Asia University’s goal of leading in biomedical innovation and accelerates scientific discovery.
Professor Alireza Haghighi, co-founder of NucleicAI and chief executive at the Harvard Medical School International Center for Genetic Disease, praised Taiwan’s strong presence in biomedical research and academia. He stated that this collaboration will build a strong data infrastructure to support predictive, preventive, and precision medicine, as well as new drug discovery, helping Taiwan take the lead in next-generation health innovation.
Health Technology Insights: ENHERTU Plus Pertuzumab Gets US Priority Review for HER2+ Breast Cancer
Professor David Sinclair, a professor at Harvard Medical School and co-founder of NucleicAI, described the partnership as a visionary initiative that could change how data is used to improve human health and longevity. He expressed enthusiasm about working with Taiwanese institutions to demonstrate the potential of combining AI and life sciences on a large scale.
The collaboration will also focus on research in genomics, AI-powered analytics, and human longevity, while emphasizing data sovereignty and strong governance. Asia University plans to move its life science and healthcare data to the new platform, allowing for secure collaboration, privacy-focused analytics, AI-driven insights, and partnerships with global industry leaders. Furthermore, the university will work with other top institutions in Taiwan to securely transfer their data, strengthening national collaboration and promoting innovation across the country.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 24 September 2025
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
